Additionally, weekly injections of the Fc-FGF-21 analog AKR-001 have been found to significantly improve insulin sensitivity in patients with the T2DM, further supporting the clinical applicability of FGF-21-based therapies [287]. Here, FGF21 is linked to type 2 diabetes mellitus.